EUVIMEDEUVIMED entdecken
Crossref

2288P PSMA-REACH: Real-world effectiveness and safety of [177Lu]Lu-PSMA-617 in patients with mCRPC

P. Barthelemy, G. Roubaud, A. Flechon, A-L. Giraudet, P. Blanchard, G. Fiard, M. Pouriel, E. Duperray, F. Courbon, C. Bailly

Annals of Oncology · 2026-12 · 37 · S1354

DOI: 10.1016/j.annonc.2026.08.2575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Oncology, 2026-12. Verfasst von P. Barthelemy und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Barthelemy, P., Roubaud, G., Flechon, A., Giraudet, A., Blanchard, P., Fiard, G., Pouriel, M., Duperray, E., Courbon, F., & Bailly, C. (2026). 2288P PSMA-REACH: Real-world effectiveness and safety of [177Lu]Lu-PSMA-617 in patients with mCRPC. Annals of Oncology, 37, S1354. https://doi.org/10.1016/j.annonc.2026.08.2575

Vancouver

Barthelemy P, Roubaud G, Flechon A, Giraudet A, Blanchard P, Fiard G, et al. 2288P PSMA-REACH: Real-world effectiveness and safety of [177Lu]Lu-PSMA-617 in patients with mCRPC. Annals of Oncology. 2026;37:S1354. doi:10.1016/j.annonc.2026.08.2575

BibTeX
@article{Barthelemy2026,
  author = {Barthelemy, P. and Roubaud, G. and Flechon, A. and Giraudet, A-L. and Blanchard, P. and Fiard, G. and Pouriel, M. and Duperray, E. and Courbon, F. and Bailly, C.},
  title = {2288P PSMA-REACH: Real-world effectiveness and safety of [177Lu]Lu-PSMA-617 in patients with mCRPC},
  journal = {Annals of Oncology},
  year = {2026},
  volume = {37},
  pages = {S1354},
  doi = {10.1016/j.annonc.2026.08.2575}
}
Kostenlos starten →